Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.
News & Opinion
Covering the life sciences inside and out
Most Recent
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.
New computational modeling suggests pre-existing HIV drug resistance mutations may contribute more to drug failure than previously thought.
African justice systems must change to help curb HIV and tuberculosis transmission in prisons.
Engaging the brain with cognitive tasks helps paralyzed rats walk again.
A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.
Fill out our annual Salary Survey to help us calculate the most current salary data for life scientists.
Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
By discouraging change, universities are stunting scientific innovation, leadership, and growth.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- genetics & genomics
- neuroscience
- opinion
- techniques
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
